Medical Condition News

RSS

Air pollution accounts for premature deaths from cardiovascular disease

In a current opinion article "Reduction of environmental pollutants for prevention of cardiovascular disease: it's time to act", published in the European Heart Journal this week.

9 Nov 2020

Patients diagnosed with Parkinson's disease may actually have NIID, shows study

A joint study by the National Neuroscience Institute (NNI) and Singapore General Hospital (SGH) revealed that patients who have been diagnosed with Parkinson's disease might actually have NIID instead.

9 Nov 2020

RA guidelines stress on minimizing steroids and maximizing methotrexate, biologics

The American College of Rheumatology (ACR) will preview its 2020 Guideline for the Management of Rheumatoid Arthritis (RA) at ACR Convergence, the ACR's annual meeting. The comprehensive, clinical recommendations for pharmacologic treatment of RA includes important updates to the previous guideline released in 2015.

9 Nov 2020

Study examines racial disparities in underinsurance

High deductible health plans (HDHPs) have become much more common among all racial/ethnic and income groups, but the health savings accounts (HSAs) that make these plans potentially workable are far less common among Black, Hispanic, and lower-income enrollees--and the gap is growing.

8 Nov 2020

New strategy shows promises for treating RNA-repeat expansion disorders

A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle tests conducted by scientists at Scripps Research.

8 Nov 2020

Researchers launch clinical trial to assess therapeutic drug monitoring for patients with inflammatory diseases

New research presented at ACR Convergence, the American College Rheumatology's annual meeting, showed that patients with rheumatic diseases whose infliximab treatment was individually assessed and adjusted with a new strategy called therapeutic drug monitoring did not achieve remission at higher rates compared to those who received standard care.

8 Nov 2020

Delirium common after hospital discharge in critically ill COVID-19 patients

Anesthesiologist and other researchers from Michigan Medicine, Ann Arbor, New York Medical College, Valhalla and Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, have reported a case series of critically ill coronavirus disease 2019 (COVID-19) patients who have developed neuropsychological symptoms after having been discharged from the hospital.

8 Nov 2020

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

Today, the U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD).

8 Nov 2020

Biologic or targeted synthetic DMARDs reduce dementia in patients with rheumatoid arthritis

The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic DMARDs, according to a new study.

6 Nov 2020

Black patients with lupus have higher risk of stroke and ischemic heart disease

New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.

6 Nov 2020

A new method to improve the preclinical evaluation of CAR T cell therapies

Ludwig Cancer Research scientists have developed a method to significantly improve the preclinical evaluation of chimeric antigen-receptor (CAR) T cell therapies, in which the immune system's T cells are extracted from a patient, engineered to target a specific tumor-associated molecule and then grown and reinfused for cancer treatment.

6 Nov 2020

New guideline for juvenile idiopathic arthritis gives emphasis to disease-modifying treatments

The American College of Rheumatology will preview the 2021 Guideline for the Treatment of Juvenile Idiopathic Arthritis at ACR Convergence, the ACR's annual meeting.

6 Nov 2020

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

The Natural Sciences and Engineering Research Council of Canada (NSERC) supports research that results in "breakthrough answers to timeless questions." When choosing awardees, the council looks for creativity and innovation, two qualities they see at the heart of all research advances.

6 Nov 2020

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies.

6 Nov 2020

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including hydroxychloroquine, during the 2020 global coronavirus pandemic, when antimalarials were touted as a possible COVID-19 treatment.

6 Nov 2020

Study identifies key clinical features of chronic nonbacterial osteomyelitis

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, identified key clinical features of chronic nonbacterial osteomyelitis (CNO), which leads to an important step toward the development of much-needed classification criteria for a disease that affects children and young adults worldwide.

6 Nov 2020

People of color with rheumatic disease have worse COVID-19 outcomes

New research at ACR Convergence, the American College of Rheumatology's annual meeting, reveals that people of color with rheumatic disease have worse health outcomes from COVID-19 infection, are more likely to be hospitalized to treat their coronavirus infection, and are more likely to require invasive ventilator treatment

6 Nov 2020

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, discovers that use of hydroxychloroquine, a generic drug, does not cause any significant differences in QTc length or prolonged QTc, key measures of heart rate, in people with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE).

6 Nov 2020

Oral methotrexate can be an effective intervention for people with knee OA

A new study presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that after three months of treatment with oral methotrexate, adults with primary knee osteoarthritis (OA) with inflammation had significant improvements in physical function and inflammation, a sign that this inexpensive, generic pill may be an important intervention for knee OA.

6 Nov 2020

TB screening needed for people on methotrexate who live in at-risk areas

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that tuberculosis (TB) screening and ongoing clinical care is needed for people on methotrexate who live in areas where the highly infectious illness is common.

6 Nov 2020

Medical Condition News

Air pollution accounts for premature deaths from cardiovascular disease

Patients diagnosed with Parkinson's disease may actually have NIID, shows study

RA guidelines stress on minimizing steroids and maximizing methotrexate, biologics

Study examines racial disparities in underinsurance

New strategy shows promises for treating RNA-repeat expansion disorders

Researchers launch clinical trial to assess therapeutic drug monitoring for patients with inflammatory diseases

Delirium common after hospital discharge in critically ill COVID-19 patients

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

Biologic or targeted synthetic DMARDs reduce dementia in patients with rheumatoid arthritis

Black patients with lupus have higher risk of stroke and ischemic heart disease

A new method to improve the preclinical evaluation of CAR T cell therapies

New guideline for juvenile idiopathic arthritis gives emphasis to disease-modifying treatments

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

Study identifies key clinical features of chronic nonbacterial osteomyelitis

People of color with rheumatic disease have worse COVID-19 outcomes

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

Oral methotrexate can be an effective intervention for people with knee OA

TB screening needed for people on methotrexate who live in at-risk areas

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News